The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population

Journal of Urology

Volumn 157, Issue 6, 1997, Pages 2191-2196

  Bangma, Chris H ^a   Rietbergen, John B W ^a   Kranse, Ries ^a   Blijenberg, Bert G ^a   Petterson, Kim ^a   Schröder, Fritz H ^a  

^a NONE

Author keywords

biopsy; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0031005241     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(01)64712-8     Document Type: Article

References (17)

1. Mettlin, C., Lee, F., Drago, J. and Murphy, G. P.: The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer, 67: 2949, 1991.
2. Brawer, M. K., Chetner, M. P., Beatie, J., Buchner, D. M., Vessella, R. L. and Lange, P. H.: Screening for prostatic carcinoma with prostate specific antigen. J. Urol., 147: 841, 1992.
3. Labrie, F., Dupont, A., Suburu, R., Cusan, L., Tremblay, M., Gomez, J.-L. and Emond, J.: Serum prostate specific antigen as pre-screening test for prostate cancer. J. Urol., 147: 846, 1992.
4. Schröder, F. H., Denis, L. J., Kirkels, W., de Koning, H. J. and Standaert, B.: European Randomized Study of Screening for Prostate Cancer, progress report of Antwerp and Rotterdam pilot studies. Cancer, 76: 129, 1995.
5. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in early detection of prostate cancer: results of multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
6. Littrup, P. J., Kane, R. A., Mettlin, C. J., Murphy, G. P., Lee, F., Toi, A., Badalament, R. and Babaian, R.: Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer, 74: 3146, 1994.
7. Oesterling, J. E., Jacobsen, S. J. and Cooner, W. H., Jr.: The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. J. Urol., 153: 1160, 1995.
8. Christenssen, A., Björk, T., Nilsson, O., Dahlén, U., Matikainen, M. T., Cockett, A. T. K., Abrahamsson, P.-A. and Lilja, H.: Serum prostate specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150: 100, 1993.
9. Lilja, H., Björk, T., Abrahamsson, P.-A., Stenman, U.-H., Shaw, N., Dowell, B., Oesterling, J., Pettersson, K., Piironen, T. and Lövgren, T.: Improved separation between normals, benign prostatic hyperplasia (BPH), and carcinoma of the prostate (CAP) by measuring free (F), complexed (C) and total concentrations (T) of prostate specific antigen (PSA). J. Urol., part 2, 151: 400A, abstract 692, 1994.
10. King, C., Friese, J., Lauren, L., Dowell, B., Shaw, N., Lilja, H., Stenman, U., Piironen, T. and Pettersson, K.: Measurement on IMx of free and total forms of prostate specific antigen for differentiation of patients with benign prostatic hyperplasia and prostate cancer. Clin. Chem., 40: 1007, 1994.
11. Bangma, C. H., Kranse, R., Blijenberg, B. G. and Schröder, F. H.: The value of screening tests in the detection of prostate cancer. Part 1. Results of a retrospective evaluation of 1726 men. Urology, 46: 773, 1995.
12. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
13. Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J. and Cooner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol., part 2, 147: 817, 1992.
14. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 274: 1214, 1995.
15. Bangma, C. H., Kranse, R., Blijenberg, B. G. and Schröder, F. H.: The New Delfia prostate specific antigen (PSA) assays of free and total PSA: results of the first comparative evaluation. J. Urol., part 2, 153: 294A, abstract 264, 1995.
16. th International European Congress of Clinical Chemistry, Helsinki, Finland, June 1995.
17. Blijenberg, B. G., Bangma, C. H., Kranse, R., Eman, I. and Schröder, F. H.: Analytical evaluation of the new Prostatus PSA free/total assay as part of a screening study for prostate cancer. Eur. J. Clin. Chem. Clin. Biochem., in press.